MDS experts, Dr Alan List and Dr David Sallman, provide an overview of the use of
lenalidomide for
myelodysplastic syndromes (
MDS). This treatment is highly effective in patients with the chromosome 5q deletion type of MDS. It may also be used in lower-risk MDS patients. They also discuss the potential side effects of lenalidomide.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.